By Sarina Isaacs
Shares of OraSure were higher after the maker of infectious-disease diagnostic tests said it would repurchase up to $40 million of its shares.
The stock was recently up 13% at $3.87. Shares are still down nearly 40% over the past year.
The Bethlehem, Pa., company on Monday said its board has authorized the repurchase of up to $40 million of its common stock over the next two years. The buyback is to be funded by cash on hand, OraSure said.
Write to Sarina Isaacs at sarina.isaacs@wsj.com
(END) Dow Jones Newswires
March 24, 2025 10:44 ET (14:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.